Estrada GCB, Recio FI, Vega TR, Collejo RYM, Martínez OD

Language: Spanish
References: 19
Page: 870-886
PDF size: 243.43 Kb.

ABSTRACT

The 21st century has been characterized from its beginnings by a health problem that has affected the world and Cuba has not been able to escape from this situation. In late 2019, a new coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously unidentified in humans, was identified as the cause of COVID-19, with the aim of characterizing the behavior of in the cases of COVID-19 in the Granma province, a descriptive, retrospective and cross-sectional study was carried out. It is presented to the 13 confirmed cases of COVID-19 in the Granma province, between March 11, 2020 and May 31, 2020, from the beginning of the pre-epidemic phase in Cuba until May 31, 2020 in in the Granma province, 1,785 real-time PCR samples had been processed, with 0.72% being positive. In the period described, the incidence rate of the province was 1.6 per 100,000 inhabitants. The male sex predominated slightly with 53.8%, the age group with the highest incidence was 20 to 49 years with six cases (45.1%), the majority corresponded to cases that referred contact with foreigners as the source of infection the 54.0%. Granma in the period analyzed is the province with the lowest risk of becoming ill with COVID-19 in Cuba. The series was dominated by: male sex, age group 20-49 years, source of infection contact with foreigners and as a symptom, dry cough.

REFERENCES

1. Carr D. Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak. [Internet]. London: Wellcome Trust; 2020. [citado 12/03/2020]. Disponible en: https://wellcome.ac.uk/press-release/sharing-research-data-and-findings-relevant-novel-coronavirus-covid-19-outbreak

2. OMS. Los 13 desafíos de la salud mundial en esta década. Noticias Onu. [Internet]. 2020 [Citado 31/01/2020]. Disponible en: https://news.un.org/es/story/2020/01/1467872

3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395: 497-506.

4. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020; 395: 565-74.

5. Serra Valdés MA. Infección respiratoria aguda por COVID-19: una amenaza evidente. Rev haban cienc méd2020; 19(1):1-5.

6. Cabrera Gaytán DA, Vargas Valerio A, Grajales Muñiz C. Infección del nuevo coronavirus: nuevos retos, nuevos legados. Rev Méd Inst Mex Seguro Soc2014;52(4):438-41.

7. Li Q, Guan X, Wu P, Wuang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020; 382: 1199-1207.

8. OMS. Intervención del Director General de la OMS en la conferencia de prensa sobre el 2019-nCoV del 11 de febrero de 2020. OMS. [Internet].2020 [citado 12/03/2020]. Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

9. Cuba. Centro Nacional de Información de Ciencias Médicas. Nota informativa sobre la COVID-19 en Cuba: 19 de abril. Infomed. [Internet]. 2020 [citado 4/5/2020]. Disponible en: https://temas.sld.cu/coronavirus/2020/04/20/nota-informativa-sobre-la-covid-19-en-cuba-19-de-abril/

10. Martínez L. Covid-19: Cuba entró en fase de transmisión autóctona limitada. Cubadebate. [Internet]. 2020 [citado 4/5/2020]. Disponible en: http://www.cubadebate.cu/noticias/2020/04/07/cuba-en-fase-de-transmision-autoctona-limitada/

11. Díaz-Canel M, Núñez Jover J. Gestión gubernamental y ciencia cubana en el enfrentamiento a la COVID-19. Anales de la Academia de Ciencias de Cuba. [Internet]. 2020 [citado 4/5/2020]; 10(2). Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/881 12. Trilla A. Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19. Medicina Clínica2020; 154(5):175-7.

12. OMS. Preguntas y respuestas sobre la enfermedad por coronavirus (COVID 19). OMS. [Internet]. 2020 [Citado 29/03/2020]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses

13. Carod J. Agente causal: SARS-CoV-2. Cap. 2. En: Ezpeleta D, García Azorín D. Manual COVID-19 para el neurólogo general.[Internet]. Madrid: Ediciones SEN; 2020. [citado 5/5/2020]. Disponible en: https://www.sen.es/attachments/article/2677/Manual_neuroCOVID-19_SEN.pdf

14. Redacción Cubadebate. Conferencia de prensa de MINSAP, Dr. Durán. 31 de mayo de 2020. Cubadebate. [Internet]. 2020 [4/5/2020]. Disponible en: http://www.cubadebate.cu/noticias/2020/05/31/cuba-reporta-20-nuevos-casos-positivos-a-la-covid-19-y-14-altas-medicas-video/

15. Pérez Abreu MR, Gómez Tejeda JJ, Diéguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev haban cienc méd [Internet]. 2020 [citado 4/5/2020]; 19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505

16. Rodríguez-Morales AJ, Cardona Ospina JA, Gutiérrez Ocampo E, Villamizar Peña R, Holguin Rivera Y, Escalera Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel MedInfect Dis [Internet]. 2020 [citado 26/03/2020]; 34. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32179124/

17. Ministerio de Salud Pública. Protocolo de Actuación Nacional para la COVID-19. [Internet]. 2020 [citado 4/5/2020]. Disponible en: http://www.sld.cu/anuncio/2020/05/11/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid-19

18. Cheng N. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395: 507–13.

19. Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA 2020; 323(8):707-8.